original ) (raw )Characteristics of Androgen Deficiency in Late-Onset Hypogonadism: Results from the European Male Aging Study (EMAS)
felipe casanueva
The Journal of Clinical Endocrinology & Metabolism, 2012
View PDFchevron_right
The association of obesity with sex hormone‐binding globulin is stronger than the association with ageing – implications for the interpretation of total testosterone measurements
Alvin Matsumoto
Clinical Endocrinology, 2015
View PDFchevron_right
Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight
Berniza Calderon
Andrology, 2015
View PDFchevron_right
High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment
Hans Boer
The Netherlands Journal of Medicine
View PDFchevron_right
Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy
Georgios Valsamakis
Endocrine, 2018
View PDFchevron_right
Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone
Michaël R Laurent
View PDFchevron_right
The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men
Carolyn Allan
The Medical journal of Australia, 2006
View PDFchevron_right
Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study
Antonio Aversa
Journal of Endocrinological Investigation, 2014
View PDFchevron_right
Measurement of Serum Testosterone in Nondiabetic Young Obese Men: Comparison of Direct Immunoassay to Liquid Chromatography-Tandem Mass Spectrometry
José Carlos Fernández García
Biomolecules, 2020
View PDFchevron_right
Insulin resistance and sex hormone-binding globulin are independently correlated with low free testosterone levels in obese males
Davide Carvalho
Andrologia, 2018
View PDFchevron_right
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity
Dheeraj Kapoor
Diabetes Care, 2007
View PDFchevron_right
Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat
Nicolau Lima
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2000
View PDFchevron_right
Total Serum Testosterone Level in Obese Patients with Type -2 Diabetes Mellitus
rehab badi
International Journal of Life Science and Pharma Research, 2021
View PDFchevron_right
Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes
Firouz Amani
2021
View PDFchevron_right
Metabolic Disorders and Male Hypogonadotropic Hypogonadism
Cristina de Angelis
Frontiers in Endocrinology
View PDFchevron_right
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial)
Ivan Zuran
The Aging Male, 2020
View PDFchevron_right
Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update
Bruno Lunenfeld
The Aging Male, 2013
View PDFchevron_right
Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based Sample
Thomas Travison
The Journal of Clinical Endocrinology & Metabolism, 2008
View PDFchevron_right
Baseline Data From the TRiUS Registry: Symptoms and Comorbidities of Testosterone Deficiency
Gary Blick
Postgraduate Medicine, 2011
View PDFchevron_right
Controversies in the laboratory evaluation of hypogonadism: Androgen deficiency algorithm
Wayne Hellstrom
Current Sexual Health Reports, 2007
View PDFchevron_right
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Michael Perelman
Diabetes Care, 2011
View PDFchevron_right
Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism
Alper Sonmez
European Journal of Endocrinology, 2011
View PDFchevron_right
The complications of male hypogonadism: is it just a matter of low testosterone?
alessandro amodeo
Frontiers in Endocrinology
View PDFchevron_right
Calculated free testosterone and radioimmunoassay free testosterone as a predictor of subnormal levels of total testosterone
Ernani Luis Rhoden
International Urology and Nephrology, 2011
View PDFchevron_right
Testosterone Concentrations in Diabetic and Nondiabetic Obese Men
D. Mager , Paresh Dandona
Diabetes Care, 2010
View PDFchevron_right
Testosterone for Androgen Deficiency-Like Symptoms in Men Without Pathologic Hypogonadism: A Randomized, Placebo-Controlled Cross-Over with Masked Choice Extension Clinical Trial
Shao Feng Mok
The Journals of Gerontology: Series A, 2019
View PDFchevron_right
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Thomas Jones
Diabetes Care, 2007
View PDFchevron_right
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males
Ronald Swerdloff
The Aging Male, 2009
View PDFchevron_right
Marked Testosterone Deficiency-Related Symptoms May be Associated to Higher Metabolic Risk in Men with Low Testosterone Levels
Javier Romero-Otero
The Journal of Sexual Medicine, 2014
View PDFchevron_right
Clinical and biochemical correlates of hypogonadism in men with type 2 diabetes mellitus
Ezekiel Musa
Pan African Medical Journal
View PDFchevron_right